Linde North America, Inc. is 10% Owner at Bellerophon Therapeutics, Inc. (BLPH). They have made 1 open-market trade across 1 company since 2015, most recently 2017-09-29.
CIK 0001505451
1 open-market purchase totalling $4.3M since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BLPH | 1,920,000 | $197K |
Shares reported on the most recent Form 4, priced at the 2018-01-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLPH | BUY | 2015-02-19 | 2015-02-23 | $12.00 | $4.3M | -13.1% | -0.7% | -0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.